TrialNature medicine2024

p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial.

Hayley R C Shanks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.